Skip to main content
main-content

09-11-2017 | ACR/ARHP 2017 | Video

Expert commentary: Biologic use during pregnancy and infection risk in infants

Bonnie Bermas provides an independent viewpoint on the results of a study suggesting that the use of biologic agents by women with rheumatoid arthritis during pregnancy is not associated with an increased serious infection risk for their babies.